StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.Falco, Miriam. (Sept. 7, 2012). "A tiny step forward for spinal cord injuries."Le Roux, Mariette. (March 5, 2014). "Science sees future beyond Paralympics."
They are being studied in early stage trials.http://www.clinicaltrials.gov/ct2/show/NCT02163876
In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.
References
External links StemCells, Inc. website